View BML Technology Founder Marc Saab participate in the Venture135 Conference, DHIT Panel Discussion: Moving the Needle from Healthcare to Health
Our founder and Managing Director Marc Saab participated in an Expert Panel discussion administered by DHIT: Digital Health Institute for Transformation, as part of the Venture135 Conference on Nov 17, 2021. The Panel discussion topic was ‘Moving the Needle from Healthcare to Health’ and it took place during the Healthtech portion of the event.
The discussion was lively and insightful as the various participants contributed their experiences and outlook to the complex issue of how the potential of health tech can be made real by delivering on the promise of better health outcomes for patients.
Venture135 is a premier venture capital conference focusing on generating quality deal flow and innovation across the fintech, insurtech, healthtech & cleantech verticals.
View the Expert Panel discussion:
Day 2 | Wednesday, November 17 | Insurtech & Healthtech
3:00PM EST | Health Tech: Moving the Needle from Healthcare to Health (Healthtech)
This panel of international healthcare executives will dive into the topic of how health tech is helping move the needle from healthcare to health. Focus will center around international health tech trends from solutions, to purchasing behaviors, to adoption practices that are leading the way.
The Panel was moderated by Michael Levy, Co-founder and CEO of DHIT, the Digital Health Institute for Transformation, a 501(c) (3) non-profit education and research institute supporting communities through the process of digital health transformation.
Panel Discussion Featuring:
About BML Technology
BML Technology understands digital health. At the intersection of medical technology, clinical research and patient-centric healthcare BML drives the mainstream adoption of digital technology in healthcare. Offering a full range of services to the digital health ecosystem BML manages the complex stakeholder interactions necessary to get digital health solutions to market and gain adoption.